A Study on the Effect of St, Thomas' Cavdioplegic Solution in the Cultured Rat Myocardial Cells

심정지액이 백서 배양 심근세포에 미치는 영향

  • 임진수 (조선대학교 의과대학 흉부외과학교실) ;
  • 정연태 (원광대학교 의과대학 해부학교실)
  • Published : 1996.04.01

Abstract

In an attempt to evaluate the effect of St. Thomas' hospital cardioplegic solution (STH) I and II on the cultured rat myocardial cells, beating rate, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (Irtrazolium MTT) and lactate dehydrogenase activity were investigated, and also light and electron microscopic studies were carried out. After rat myocardial cells were cultured for 72 hours, cells were treated with STH I or with STH H solution for 30 and 120 min. and thereafter myocardial cells were cultured in control medium for 24 hours. The results obtained were as follows : 1. Beating rate was 154 times per min. in control group, 141 times per min. in STH I solution(for 2. 120 min.)-treated group and 145 times in STH ll solution (for 120 min.)-treated group. MTT absorbances by MTT assay were 102% in STH I solution (for 120 min.)-treated group and 93% in STH ll solution (for 120 min.)-treated group compared with control group. 3. The amount of lactate dehydrogenase released into the medium were 123% in STH I solution (for 120 min.)-treated group and 109% in STH H solution (for 120 min.)-treated group compared with control group. 4. In the light microscopy examination, myocardial cells showed no differences between experimental and control groups in their number and shape. 5. In the electron microscopy examination, myocardial cells treated with STH I solution showed fewer destroyed mitochondria compared to STH ll solution-treated group. These results suggest that both 51. Thomas'cardioplegic solution STH 1 and STH H have no cytotoxicity on cultured rat myocardial cells, but STH H solution has more protective effect on myocardial cells compared to STH I solution.

St. Thomas' 심정지액 I과 II가 백서 배양심근세포에 미치는 영향을 알아보기 위하여 심장 박동수, MTT 정량, LDH 정량 및 형태학적 관찰을 시행하였다. 백서의 심근 세포를72시간 배양한 후St. Thomas' 심정지액 I과 H에 30분및 120분간 처리한후24 시간 동안 배양하여 다음과 같은 결과를 얻었다. 1. 심근 세포 박동수는 대조군이 분당 154회, St. Thomas' 심정지액 I 에 120분 처리한 실험군에서는 147회, II 120분처리군에서는 145회로대조군에 비하여 유의한 차이를 보이지 않았다. 2. MTT 정량 결과St. Thomas' 심정지액 1120분 처리군에서는대조군의 102%로나타났으며. R B2O 분처리군에서는 93%로 대조군에 비하여 유의한 차이를 보이지 않았다. 3. LDH정량 결과 St. Thomas' 심정지액 1120분처리군에서는대조군의 123%로나타났으며, R 120 분처리군에서는 109%로 약간의 증가를 보였다. 4. 광학현미경적 관찰결과세포수및 세포 형태에 있어서 대조군과 실험군간에 차이를 보이지 않았다. 5.전자현미경적 관찰 결과St. Thomas'심정지액 I 처리군에서는소수의 미토콘드리아파괴가관찰되 었으며, II 처리군에서는대조군과유사한소견을보였다. 이상의 실 瘟嘯倖?종합하여 볼때, St. Thomas'심정지액 I과 II는백서 배양심근세포에 세포독성 을 나타내지 않았으나,전자현미경적 관찰결과심정지액 II가심정지액 I에 비하여 심근보호효과가 더 양호한 것으로 생각된다.

Keywords

References

  1. Ann Thoracic Surg v.57 Effect of magnesium and calcium on myocardial protection by cardioplegic solutions Takemoto N;Kuroda H;Hamasaki T;Hara Y;Ishiguro S;Mori T
  2. Circ Res v.67 Effect of acidosis on intracellular pH and calcium concentration in the newborn and adult rabbit myocardium Nakanishi T;Seguchi M;Tsuchiya T;Yasukouchi S;Takao A
  3. J Thorac Cadiovasc Surg v.104 The effect of intramyocardial pH on functional recovery on neonatal hearts receving St, Thomas' hospital cardioplegic solution during global ischemia Iannettoni MD;Bove EL;Fox MH;Groh MA;Bolling SF;Gallagher KP
  4. J Thorac Cadiovasc Surg v.105 The optimal glucose concentration of intermittent cardioplegic in isolated rat heart when added to St. Thomas' hospital cardioplegic solution Owen P;du Toit EF;Opie LH
  5. J Thorac Cadiovasc Surg v.103 Long-term preservation of explanted hearts perfused with L-aspartate-enriched cardioplegic solution Choong YS;Gavin JB;Buckmann J
  6. JJATS v.29 Cardiac function study of the isolated canine heart by use of newly disigned perfusion apparatus Kawakami T;Watanabe F;Takahashi J;Mats M
  7. J Thorac Cadiovasc Surg v.69 An experimental model for studying myocardial ischemia Liedtke AJ;Hughes HC;Neely JR
  8. Exp Cell Res v.155 Cardiomyocytes cultured in serum-free medium-Growth and creatine kinase activity Kessler-Icekson G;Sperling O;Retem C;Wasserman L
  9. Chem Pharm Bull v.35 Effect of adriamycin on cultured mouse embryo myocardial cells Takahashi K;Fujita Y;Mayumi T;Kishi T
  10. Kor J Anat v.27 Cytotoxicity and recorvery of bupivacaine in myocardial cells of neonatal rat in vitro Kim YI
  11. Cancer Res v.47 Evaluation of a tetrazolium-based semiautomatic colorimetric assay:assesment of radiosensitivity Carmichael J;Dectraff WB;Gazder AF;Minna JD;Mitchell JB
  12. J Immunol Meth v.65 Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays Mosmann T
  13. Toxicol in Vitro v.7 Cell cultures. A tool for the study of mechanisms of toxicity Galli Cl;Viviani B;Marinovich M
  14. A Textbook of Cardioplegia for Difficult Clinical Problems 2nd ed. European of cardioplegia Braimbridge MV;Engelman RM(ed.);Levitsky S(ed.)
  15. 대흉외지 v.25 백서의 적출된 심장에서 심정지액의 산소화가 허혈성 심정지후 심기능의 회복에 미치는 영향(Ⅱ) 최종범;임태근;윤재도;최순호;최봉규
  16. J Thorac Cadiovasc Surg v.75 Clinical experience using potassium-induced cardioplegia with hypothermia on aortic valve replacement Adams PX;Cunninhgham JW;Trahan NK;Brazier JR;Reed GE;Spencer FC
  17. J Thorac Cadiovasc Surg v.76 Potassium-induced cardioplegia Craver JM;Sams AB;Hatcher CR
  18. J Thorac Cadiovasc Surg v.16 Cardioplegic cardiac arrest in aortic surgery Sondergaard T;Berg E;Staffeidt I;Szczepanski K
  19. J Thorac Cadiovasc Surg v.79 Safety of prolonged ischemic arrest using hypothemic cardioplegia Hultgren HN;Mijagawa M;Vertrees RA(et al)
  20. J Supermol Struct v.9 Spin label studies on rat liver and heart plasma membranes:effects of temperature, calcium and lanthanum in membrane fluidity Gordon LM;Sauerheber RD;Esgate JA
  21. Physiol Rev v.57 Relationship between calcium and cyclic nucleotides in cell activation Ramussen H;Goodmann DP
  22. J Thorac Cadiovasc Surg v.93 Optomal myocardial presevation with an acalcemic crystalloid cardioplegic solution Boggs BR;Torchiana DF;Geffin GA(et al)
  23. J Thorac Cadiovasc Surg v.101 Lowering the calcium concentration in St. Thomas' hospital cardioplegic solution improves protection during hypothemic ischemia Robinson LS;Harwood DL
  24. Am heart J v.108 Magnesium: nature's physiologic calcium blocker Iseri LT;French JH
  25. J Thorac Cadiovasc Surg v.75 Myocardial protection during ischemic cardiac arrest. The important of magnesium in cardioplegic infusates Hearse DJ;Stewart DA;Braimbridge MV
  26. Jpn Circ J v.44 Effect of magnesium in cardioplegic solution upon hypothemic ischemic myocardial mitochondria Sunamori M;Suzuki A;Harrison CE
  27. Circ Res v.33 Magnesium in heart muscle Polimeni PI;Page E
  28. Biochemistry v.11 Studies on the role of Mg^++ and Mg^++ stimulated adenosine triphosphatase in oxidative phosphorylation Chao DLS;Davis DJ
  29. Exp cell Res v.56 Synchronized beating of embryonic mouse myocardial cells mediated by FL cells in monolayer culture Goshima K;Tonomura Y
  30. Chonnam J Med Sci v.1 A study on the cytotoxicity of adriamycin on cultured rat myocardial and endotherial cells Chung YT;Choi MK;Kim JM;Park ST
  31. Path Res Pract v.188 Morphomrtric analusis on myocardial injury related to the use if high volume potassium cardioplegic solution during ischemic arrest Li Q;MacAulay MA;Landymore RW;Marble A;Dean S;Fris J;Kerstein F
  32. 대흉외지 v.13 Cardioplegic solution의 심근보호 효과에 관한 실험적 연구 이종국